Method for preparing salicylamine acetate

Abstract

The present invention discloses a method for preparing salicylamine acetate, which includes the following steps: (1) protecting salicylaldehyde, the structure of which is shown in Formula 1, with an amino group to obtain a compound of which the structure is shown in Formula 2; (2) reacting the compound of which the structure is shown in Formula 2 with acetic acid to obtain salicylamine acetate.

Description

[Technical field]

[0001] The present application is in the field of chemical synthesis, and more specifically, relates to a method for preparing salicylamine acetate. [Background technology]

[0002] The compound obtained by protecting salicylaldehyde with an amino group can be hydrolyzed and deprotected with a strong acid, and then reacted with acetic acid to obtain salicylamine acetate, but the commercial value of this method is limited. Therefore, it is urgently needed in this field to provide a method for preparing salicylamine acetate with low cost and excellent commercial effect. Summary of the Invention

[0003] The object of the present application is to provide a new process for the preparation of salicylamine acetate. The present application provides a method for preparing salicylamine acetate, the method comprising the steps of: (1) protecting salicylaldehyde having the structure shown in formula 1 with an amino group to obtain a compound having the structure shown in formula 2; and (2) reacting a compound having the structure shown in formula 2 with acetic acid to obtain salicylamine acetate;

[0004] [ka]

[0005] In another preferred example, in step (1), the reaction temperature for protecting the amino group is 0-50°C. In another preferred embodiment, the reaction time for protecting the amino group in step (1) is 3 to 18 hours.

[0006] In another preferred embodiment, in step (1), the equivalent ratio of tert-butyl carbamate to salicylaldehyde is 1.0-3.0:1. In another preferred embodiment, the reaction solvent in step (1) is selected from tetrahydrofuran, 2-methyltetrahydrofuran, acetonitrile, or 1,4-dioxane.

[0007] In another preferred embodiment, in step (2), the reaction temperature with acetic acid is from 50° C. to the reflux temperature of acetic acid, more preferably from 70° C. to the reflux temperature of acetic acid. In another preferred embodiment, in step (2), the reaction time with acetic acid is 5-70 hours, more preferably 5-60 hours.

[0008] In another preferred embodiment, in step (2), the ratio of the amount of the compound having the structure shown in Formula 2 to acetic acid is 1:0.1-20 (g / mL); more preferably, 1:1-15 (g / mL); and even more preferably, 1:3-10 (g / mL).

[0009] In another preferred embodiment, the method comprises the steps of: (1) Salicylaldehyde having the structure shown in formula 1 is protected with an amino group to obtain a compound having the structure shown in formula 2; (2) reacting the compound having the structure shown in formula 2 with acetic acid, stopping the reaction, and then lowering the temperature to room temperature to obtain crude salicylamine acetate; and (3) The resulting crude salicylamine acetate is mixed with an organic solvent to precipitate crystals, thereby obtaining pure salicylamine acetate; the organic solvent can be selected from ethyl acetate, isopropyl ether, absolute ethanol, or methyl tert-butyl ether.

[0010] In another preferred embodiment, the amount of the organic solvent used is 1 to 50 times the amount of the compound of formula 2 used; more preferably, 1 to 20 times; and even more preferably, 1 to 10 times. Therefore, the present application provides a method for preparing salicylamine acetate which has low cost and good commercial effectiveness. [Brief description of the drawings]

[0011] [Figure 1] FIG. 1 shows the NMR spectrum of the salicylamine acetate obtained in the present application. [Diagram 2] FIG. 2 shows the HPLC spectrum of the salicylamine acetate obtained in the present application. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0012] Specific embodiments The removal of the amino group protecting agent cannot be achieved with a weak acid such as acetic acid, so it is generally carried out by hydrolysis with a strong acid. For example, the following series of reactions are shown below:

[0013] [ka]

[0014] The reaction conditions and results are shown in Table 1:

[0015] [Table 1]

[0016] The above reactions showed that the effect of deprotecting the amino group with acetic acid is not good for amino group protecting agents on benzene ring or other rigid structures; the raw materials of different substrates could be detected by LCMS to produce the target products, but the amount of impurities produced (especially for reactions a and b) was large; in the workup of the three reactions, the addition of methyl tert-butyl ether did not precipitate any solid, so the purification process would be very troublesome if we intend to obtain the target products.

[0017] However, the target product of the present application is salicylamine acetate, and by using acetic acid, the deprotection and salt formation can be completed in one step; the teachings provided in the prior art are that the yield of such a reaction is low or the post-treatment is complicated, which is not favorable for industrial production. However, the inventors have found through extensive and detailed research that when several key factors are properly controlled in the complex reaction environment, the salicylaldehyde compound obtained by using the amino-protecting reagent can not only be directly reacted with acetic acid to obtain salicylamine acetate, but also can be crystallized using an organic solvent to obtain a high-purity product.

[0018] The above-mentioned so-called important factors include the relationship between the amount of reactant and acetic acid, the reaction temperature and time, and the selection of the organic solvent in the subsequent crystallization process. Based on this, the present invention has been completed.

[0019] As used herein, "a compound having the structure shown in Formula 1" and "a compound of Formula 1" are used interchangeably and both refer to salicylaldehyde. The rest can be inferred by analogy.

[0020] As used herein, "room temperature" refers to a temperature between 15-35°C, for example, but not limited to, 15-20°C, 15-25°C, 18-20°C, 15-30°C, 22-28°C, 24-30°C, 32-35°C, etc. The compounds involved are listed in Table 2:

[0021] [Table 2]

[0022] Specifically, the method for preparing salicylamine acetate, the structure of which is shown in formula 3, provided herein includes the following steps: Step 1, salicylaldehyde having the structure shown in formula 1 is mixed with an amino group protecting agent to obtain a compound having the structure shown in formula 2; Step 2, a compound having the structure shown in Formula 2 is mixed with acetic acid and reacted to give salicylamine acetate having the structure shown in Formula 3.

[0023] In one embodiment of the present invention, in the above step 1, the solvent contained in the system comprising the salicylaldehyde having the structure shown in formula 1 and the amino group protecting agent is selected from tetrahydrofuran, 2-methyltetrahydrofuran, acetonitrile, or 1,4-dioxane.

[0024] In one embodiment of the present invention, step 1 above includes triethylsilane in the system comprising salicylaldehyde having the structure shown in Formula 1 and an amino group protecting agent.

[0025] In one embodiment of the present invention, step 1 above further comprises the addition of trifluoroacetic acid to the system comprising the salicylaldehyde having the structure shown in formula 1 and the amino group protecting agent.

[0026] In one embodiment of the present invention, the mixing temperature in the above step 1 is 0-50°C, preferably 10-50°C. In one embodiment of the present invention, the mixing time in step 1 above is 3-18 hours, preferably 8-18 hours.

[0027] In one embodiment of the present application, the above step 1 comprises mixing salicylaldehyde having the structure shown in formula 1, an amino group protecting agent, triethylsilane and trifluoroacetic acid, and then incubating the system at 0-50°C (preferably 10-50°C) for 3-18 hours (preferably 8-18 hours) to obtain a compound having the structure shown in formula 2; wherein the amino group protecting agent is selected from benzyl carbamate or tert-butyl carbamate; the ratio of the amount of the amino group protecting agent to the salicylaldehyde is 1.0-3.0 equivalents:1; the ratio of the amount of the triethylsilane to the salicylaldehyde is 1.0-3.0 equivalents:1.

[0028] In one preferred embodiment of the present application, the system was agitated during incubation. When tert-butyl carbamate is used in the above step 1, it is mixed with an organic solvent, and the organic solvent can be selected from tetrahydrofuran, 2-methyltetrahydrofuran, acetonitrile, or 1,4-dioxane.

[0029] In one preferred embodiment of the present application, in the above step 1, a saturated inorganic alkaline solution is used to quench the reaction to obtain the compound of formula 2; the above inorganic base includes sodium bicarbonate, potassium bicarbonate, potassium carbonate, sodium carbonate, sodium hydroxide, lithium hydroxide, etc.; the inorganic alkaline solution is used in an amount that can quench the reaction, preferably in an amount that makes the system weakly alkaline (e.g., pH is 7-9, 7-8.5, 7-8, 7.5-8.5, 7.5-9, etc.).

[0030] In one embodiment of the present invention, in the above step 2, the ratio of the amount of the compound of formula 2 to acetic acid is 1:0.1-20 (g / mL); preferably, 1:1-15 (g / mL); more preferably, 1:3-10 (g / mL).

[0031] In one embodiment of the present invention, in the above step 2, the reaction temperature with acetic acid is from 50° C. to the reflux temperature of acetic acid; preferably from 70° C. to the reflux temperature of acetic acid. In one embodiment of the present invention, in the above step 2, the reaction time with acetic acid is 5-70 hours; preferably 5-60 hours.

[0032] Regarding the reaction effect, in the above step 2, there is a relationship between the reaction temperature and the reaction time, and the higher the reaction temperature, the shorter the reaction time, and vice versa, for example, the reaction temperature is lower than 70°C, the reaction time is more than 35 hours, but the reaction temperature is higher than 100°C, the reaction time may be less than 15 hours, but is not limited thereto.

[0033] In one preferred embodiment of the present invention, the system is mixed with acetic acid, and an organic solvent is added to the system to crystallize and precipitate, and after filtration, high purity salicylamine acetate is obtained; the amount of the organic solvent used is 1-50 times the amount of the compound of formula 2 used; preferably 1-20 times; more preferably 1-10 times; the organic solvent can be selected from ethyl acetate, isopropyl ether, absolute ethanol, or methyl tert-butyl ether (MTBE).

[0034] In one preferred embodiment of the present invention, the method for preparing salicylamine acetate, the structure of which is shown in formula 3 provided herein, comprises the following steps: Step 1, salicylaldehyde having the structure shown in formula 1 is mixed with an amino group protecting agent to obtain a compound having the structure shown in formula 2; Step 2: The compound having the structure shown in formula 2 is mixed with acetic acid to react, and after the reaction is stopped, the temperature is lowered to room temperature to obtain crude salicylamine acetate; Step 3: Mix the crude salicylamine acetate with an organic solvent to crystallize and precipitate, thereby obtaining high purity salicylamine acetate having the structure shown in formula 3.

[0035] In one embodiment of the present invention, the amount of the organic solvent used in step 3 is 2-5 times (v / v) the amount of acetic acid used in step 2, and preferably 2-4 times. The above features mentioned in the present invention or the features mentioned in the embodiments can be combined in any way. All features disclosed in the present specification can be used in any configuration, and each feature disclosed in the specification can be replaced with any alternative function that can provide the same, equal or similar purpose. Therefore, unless otherwise specified, the features disclosed are merely general examples of equivalent or similar functions.

[0036] The main advantages of this invention are: 1. The preparation process of salicylamine acetate provided in the present invention requires fewer raw materials, has a shorter route and is less costly. 2. The preparation method of salicylamine acetate provided in the present invention is suitable for commercial use. 3. The salicylamine acetate obtained by the method of the present invention has good appearance.

[0037] The present invention will be further described below with reference to specific examples. It should be understood that these examples are merely illustrative of the present invention, and do not limit the scope of the present invention. Experimental methods without specific conditions in the following examples generally follow normal conditions or manufacturer's recommended conditions. Unless otherwise specified, all percentages, ratios, proportions, or parts are by weight. The units of weight-volume percentages in the present invention are known to those skilled in the art, for example, the weight of solute in 100 ml of solution. Unless otherwise defined, all technical and scientific terms used herein are consistent with the meanings known to those skilled in the art. Furthermore, any methods and materials similar or equivalent to those described can be applied to the method of the present invention. The preferred embodiments and materials described herein are for illustrative purposes only.

[0038] The purity of the compound of formula 3 in the following examples is measured by high performance liquid chromatography, in which the stationary phase of the high performance liquid chromatography is C18, the mobile phase is trifluoroacetic acid and acetonitrile aqueous solution, and the detection wavelength is 220 nm; the purity is the percentage of the sum of the peak areas of the compound of formula 3 and the sum of each peak area.

[0039] Example 1

[0040] [ka]

[0041] Acetonitrile (168.0 g) and the main raw material salicylaldehyde (70.4 g, 1.00 eq) were added into a 1L reaction flask; tert-butyl carbamate (74.0 g, 1.10 eq) and triethylsilane (79.0 g, 1.20 eq) were added into a 1L reaction flask, and trifluoroacetic acid (65.4 g, 1.00 eq) was added into the reaction system at 15°C-40°C; after the dropping was completed, the system was kept at 15-40°C and stirred for 12-16 hours before sampling, and sampling was performed every 2-4 hours; HPLC was followed and the system was quenched by adding 525 g of saturated sodium bicarbonate solution (490 g water + 35 g sodium bicarbonate) while controlling the temperature at 15-30°C (pH = 1.00-1.00%). 7-8 to a specific dosage; then it was extracted twice with ethyl acetate, 252g each time, the organic phases were combined and washed with 280g water and 336g saturated brine (252g water + 84g sodium chloride); 100g anhydrous sodium sulfate was added to the salt-washed organic phase, stirred and dried for 2-4 hours, centrifuged or suction filtered, the filter cake was rinsed with 63g ethyl acetate, the filter cake was temporarily stored, and the filtrate was combined for the next step (Example 2).

[0042] Examples 2 to 9

[0043] [ka]

[0044] The spectral data of the product obtained are: 1 H NMR:DPC0126-31-P1A 400MHz DMSO-d 6 1 H NMR (400MHz, DMSO-d 6 ) δ = 7.14 - 7.04 (m, 2H), 6.78 - 6.68 (m, 2H), 3.85 (s, 2H), 1.82 (s, 3H) MS 124.1:M+1, 107.1:M-16 The preparation process is:

[0045] Example 2 The compound of formula 2 (2.0 g) and glacial acetic acid (2.0 mL) were added to each reaction flask, stirred, and reacted at 70-80°C for 50-55 hours. The reaction was stopped, cooled to room temperature, MTBE (6 mL) was slowly added to precipitate crystals, stirred at 10-20°C for 0.5 hours, filtered, and vacuum dried at 40°C until a constant weight was reached; weight: 0.75 g; yield: 45.73%; purity: 98.43%

[0046] Example 3 The compound of formula 2 (2.0 g) and glacial acetic acid (8.0 mL) were added to a reaction flask, stirred, and reacted at 70-80°C for 50-55 hours, and the reaction was stopped. After the reaction was completed, the mixture was cooled to room temperature, and MTBE (24 mL) was slowly added to precipitate crystals. The mixture was stirred at 10-20°C for 0.5 hours, filtered, and vacuum dried at 40°C until a constant weight was reached; weight: 0.81 g; yield: 49.39%; purity: 100.00%.

[0047] Example 4 The compound of formula 2 (2.0 g) and glacial acetic acid (12.0 mL) were added to a reaction flask, stirred, and reacted at 70-80 °C for 50-55 hours. The reaction was stopped, cooled to room temperature, and MTBE (36 mL) was slowly added to precipitate crystals. The mixture was stirred at 10-20 °C for 0.5 hours, filtered, and vacuum dried at 40 °C until a constant weight was reached; weight: 0.79 g; yield: 48.17%; purity: 99.93%.

[0048] Example 5 The compound of formula 2 (2.0 g) and glacial acetic acid (20.0 mL) were added to a reaction flask, stirred, and reacted at 70-80°C for 50-55 hours. The reaction was stopped, cooled to room temperature, and MTBE (60 mL) was slowly added to precipitate crystals. The mixture was stirred at 10-20°C for 0.5 hours, filtered, and vacuum dried at 40°C until a constant weight was reached; weight: 0.95 g; yield: 57.93%; purity: 100.00%.

[0049] Example 6 The compound of formula 2 (10.0 g) and glacial acetic acid (50.0 mL) were added to a reaction flask, stirred, and reacted at 60°C for 48 hours. The reaction was stopped, cooled to room temperature, and MTBE (60 mL) was slowly added to precipitate crystals. The mixture was stirred at 10-20°C for 0.5 hours, filtered, and vacuum dried at 40°C until a constant weight was reached; weight: 1.00 g; yield: 12.20%.

[0050] Example 7 The compound of formula 2 (10.0 g) and glacial acetic acid (50.0 mL) were added to a reaction flask, stirred, and reacted at 80-90°C for 17-18 hours. The reaction was stopped, cooled to room temperature, and MTBE (150 mL) was slowly added to precipitate crystals, stirred at 10-20°C for 0.5 hours, filtered, and dried in vacuum at 40°C until constant weight; weight: 4.20 g; yield: 51.22%; purity: 97.19%.

[0051] Example 8 The compound of formula 2 (10.0 g) and glacial acetic acid (50.0 mL) were added to a reaction flask, stirred, and reacted at 90-100°C for 13-14 hours. The reaction was stopped, cooled to room temperature, MTBE (150 mL) was slowly added to precipitate crystals, stirred at 10-20°C for 0.5 hours, filtered, and dried in vacuum at 40°C until constant weight; weight: 5.11 g; yield: 62.32%; purity: 100.00%.

[0052] Example 9 The compound of formula 2 (10.0 g) and glacial acetic acid (50.0 mL) were added to a reaction flask and stirred. The mixture was refluxed for 6-7 hours, after which the reaction was stopped, cooled to 20°C, MTBE (150 mL) was slowly added to precipitate crystals, stirred at 10-20°C for 0.5 hours, filtered, and vacuum dried at 40°C until a constant weight was reached; weight: 5.50 g; yield: 67.07%; purity: 98.64%.

[0053] Example 10 The compound of formula 2 and glacial acetic acid were added to a reaction flask respectively, stirred and reacted at 90-100°C. After the reaction was completed, it was cooled to room temperature, weighed out the reaction solution (120.6g), divided equally into 10 parts (each part theoretically contains 1.64g product), and added solvent to crystallize: 1) Take a portion (12.06 g) and add petroleum ether (36 mL), no solid precipitates (system is stratified); then add MTBE (36 mL), a large amount of solid precipitates, filter and dry at 40°C to constant weight; weight: 1.03 g; yield: 62.80%; 2) Take a portion (12.04 g) and add n-hexane (36 mL), no solid precipitates (system is stratified); then add MTBE (36 mL), a large amount of solid precipitates, filter and dry at 40°C to constant weight; weight: 1.07 g; yield: 65.24%; 3) Take a portion (12.05 g) and add cyclohexane (36 mL), no solid precipitates (system is stratified); then add MTBE (36 mL), a large amount of solid precipitates, filter and dry at 40°C to constant weight; weight: 1.02 g; yield: 62.20%; 4) Take a portion (12.06 g) and add n-heptane (36 mL), no solid precipitates (system is stratified); then add MTBE (36 mL), a large amount of solid precipitates, filter and dry at 40°C to constant weight; weight: 1.03 g; yield: 62.80%; 5) A portion (12.06 g) was taken and ethyl acetate (36 mL) was added, a large amount of solid precipitated, filtered and dried at 40°C to constant weight; weight: 0.95 g; yield: 57.93%; 6) A portion (12.04 g) was taken and isopropyl ether (36 mL) was added, a large amount of solid precipitated, filtered and dried at 40°C to constant weight; weight: 1.05 g; yield: 64.02%; 7) A portion (12.05 g) was taken and absolute ethanol (36 mL) was added, a large amount of solid precipitated, filtered and dried at 40°C to constant weight; weight: 0.50 g; yield: 30.49%; 8) A portion (12.05 g) was taken and MTBE (36 mL) was added, a large amount of solid precipitated, filtered and dried at 40° C. to constant weight; weight: 1.00 g; yield: 60.98%.

[0054] Figures 1 and 2 provided by the present invention also show that the present invention has obtained salicylamine acetate with the correct structure and high purity. The above description is only the preferred embodiments of the present invention, and is not intended to limit the scope of the essential technical content of the present invention; the essential technical content of the present invention is broadly defined in the scope of the claims of this application; if the technical substance or method completed by others is exactly the same as or an equivalent modification of what is defined in the claims of this application, it shall be deemed to be included in the scope of the claims.

Claims

1. (1) Amino-protecting a salicylaldehyde having the structure shown in Formula 1 to obtain a compound having the structure shown in Formula 2; 【Chemistry 1】 (2) reacting a compound having the structure shown in formula 2 with acetic acid to obtain salicylamine acetate; 2. A method for preparing salicylamine acetate, comprising:

2. 2. The method according to claim 1, wherein the reaction temperature of amino protection in step (1) is 0-50°C.

3. 2. The method according to claim 1, wherein the reaction time of the amino protection in step (1) is 3-18 hours.

4. 2. The method according to claim 1, wherein the equivalent ratio of tert-butyl carbamate to salicylaldehyde in step (1) is 1.0-3.0:

1.

5. 2. The method according to claim 1, wherein the reaction solvent in step (1) is selected from tetrahydrofuran, 2-methyltetrahydrofuran, acetonitrile, or 1,4-dioxane.

6. 2. The method according to claim 1, wherein the reaction temperature with acetic acid in step (2) is from 50° C. to the reflux temperature of acetic acid.

7. 2. The method according to claim 1, wherein the reaction temperature with acetic acid in step (2) is from 70° C. to the reflux temperature of acetic acid.

8. The method according to claim 6 or 7, characterized in that the reaction time with acetic acid in step (2) is 5-70 hours.

9. The method according to claim 6 or 7, characterized in that the reaction time with acetic acid in step (2) is 5-60 hours.

10. The method according to claim 1, characterized in that the ratio of the compound having the structure shown in Formula 2 to acetic acid in step (2) is 1:0.1-20 (g / mL).

11. The method according to claim 1, characterized in that the ratio of the compound having the structure shown in Formula 2 to acetic acid used in step (2) is 1:1-15 (g / mL).

12. The method according to claim 1, characterized in that the ratio of the compound having the structure shown in Formula 2 to acetic acid used in step (2) is 1:3-10 (g / mL).

13. (1) Amino-protecting a salicylaldehyde having the structure shown in Formula 1 to obtain a compound having the structure shown in Formula 2; (2) reacting the compound having the structure shown in formula 2 with acetic acid, stopping the reaction, and then lowering the temperature to room temperature to obtain crude salicylamine acetate; and (3) mixing the obtained crude salicylamine acetate with an organic solvent to precipitate crystals to obtain pure salicylamine acetate, wherein the organic solvent is selected from ethyl acetate, isopropyl ether, anhydrous ethanol, or methyl tert-butyl ether; 2. The method according to claim 1, further comprising:

14. The preparation method according to claim 13, characterized in that the amount of said organic solvent used is 1-50 times the amount of the compound of formula 2 used.

15. The preparation method according to claim 13, characterized in that the amount of said organic solvent used is 1-20 times the amount of the compound of formula 2 used.

16. The preparation method according to claim 13, characterized in that the amount of said organic solvent used is 1-10 times the amount of the compound of formula 2 used.

Images